A health system experience with an electronic medical record based application to increase lung cancer screening.

Authors

Brandon Weckbaugh

Brandon Weckbaugh

UMKC School of Medicine, Kansas City, MO

Brandon Weckbaugh , Trent West , Melissa Rosado-de-Christenson , Timothy J. Pluard , John A Spertus , Janakiraman Subramanian

Organizations

UMKC School of Medicine, Kansas City, MO, Saint Luke's Hospital, Kansas City, MO, St Luke's Cancer Institute, Kansas City, MO, University of Missouri-Kansas City, Kansas City, MO, Saint Luke's Cancer Institute, Kansas City, MO

Research Funding

Other Foundation

Background: Screening high risk patients for lung cancer with Low Dose Computed Tomography (LDCT) reduces lung cancer-specific mortality, however its adoption in routine clinical care has been limited. We designed an Electronic Medical Record (EMR) based application to identify patients for screening in the primary care setting. Methods: A two-step screening application was created to identify patients meeting CMS criteria for LDCT screening in a visit to a primary care provider (PCP). First, the application directs medical assistants to complete a patient’s smoking history. If the patient meets eligibility for LDCT screening, step-by-step direction for PCPs to complete the screening process, including reviewing smoking history, shared decision making and ordering the LDCT scan, is initiated. We compared the number of referrals for screening LDCT in the 12-month periods before and after implementation of the screening application. Results: During the 12-month period prior to implementation of the screening application in a 18-person PCP group, there were a total of 198 referrals for LDCT screening. Of these, 162 (81.8%) were negative (CAT 1 and 2), 20 (10.1%) required follow up CT (CAT 3), 16 (8.1%) were positive (CAT 4), 3 (1.5%) required an invasive diagnostic procedure (bronchoscopy with biopsy, endobronchial ultrasound, CT guided biopsy, thoracic surgery). Cancer was diagnosed in 2 patients (1.0%), both of whom received cancer treatment. In the 12 months after implementation, referrals increased by 40% to 278. Of these, 241 (86.7%) were negative, 19 (6.8%) required follow up CT, 18 (6.5%) were positive, 4 (1.4%) required an invasive diagnostic procedure, and 3 (1.1%) were diagnosed with cancer and are receiving treatment. Major challenges include variable user compliance in completing accurate smoking history and providers ignoring alerts to initiate lung cancer screening. Conclusions: To our knowledge this is the first report on the use of an EMR based application to identify patients at risk for lung cancer. Implementation of the EMR based application correlated with an increase in referrals for LDCT screening and led to the identification of high risk lung lesions including lung cancer.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Cancer Prevention, Hereditary Genetics, and Epidemiology

Track

Prevention, Risk Reduction, and Genetics

Sub Track

Cancer Prevention

Citation

J Clin Oncol 36, 2018 (suppl; abstr 1558)

DOI

10.1200/JCO.2018.36.15_suppl.1558

Abstract #

1558

Poster Bd #

129

Abstract Disclosures

Similar Abstracts

Abstract

2023 ASCO Annual Meeting

Rates of colorectal cancer screening versus lung cancer screening: Where does the problem lie?

First Author: Sasmith R. Menakuru

First Author: Sasmith R. Menakuru

Abstract

2023 ASCO Annual Meeting

Navigation program for LDCT lung cancer screening implementation: A quality initiative.

First Author: Jasmine Shrestha